Bolt Projects Holdings, Inc.: Business Overview, Financials & Competitive Analysis
Bolt Projects Holdings develops and manufactures biomaterials for the beauty and personal care industry, primarily its proprietary vegan silk technology (b-silk and xl-silk) as biodegradable replacements for silicone ...
Cyborg Score thesis
High-risk, early-stage biomaterials player with proof-of-concept revenue but substantial execution and capital risks; suitable...
Read the full analyst-debate transcript →Get the Latest Bolt Projects Holdings, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeBolt Projects Holdings, Inc. Overview
Pro stress-test →Bolt Projects Holdings develops and manufactures biomaterials for the beauty and personal care industry, primarily its proprietary vegan silk technology (b-silk and xl-silk) as biodegradable replacements for silicone elastomers.
Strategic Profile
Pro stress-test →Bolt operates in the emerging specialty chemicals/biomaterials space with a focus on sustainable, plant-based alternatives to synthetic polymers. The company is transitioning from pre-commercialization to revenue generation, reporting 23-fold year-over-year revenue growth in Q2 2025 driven by B2B partnerships, but faces execution risks including manufacturing scale-up, limited customer base, and capital constraints.
Competitive Landscape
Pro stress-test →Bolt competes in the niche specialty chemicals and biomaterials space against established silicone elastomer suppliers and emerging bio-based polymer developers. Direct competitors include traditional beauty ingredient suppliers (e.g., Dow Corning for silicones) and emerging sustainability-focused chemistry companies, though the market remains fragmented with limited direct-to-product competitors at Bolt's stage and scale.
Industry Context
Bolt Projects Holdings, Inc. operates in Specialty Chemicals.
Key facts
Founded: 2009 · Headquarters: San Francisco, California · Employees: 14 · Revenue: Estimated $3.14M for trailing twelve months (TTM) as of filing; FY2025 preliminary results $4.5M; FY2026 guidance raised to $11M (December 2025) · Market cap: $8.7M (as of September 2026)